Genital Lesions Most Common Sign of CCD
A recent study found that genital lesions are the most common sign of cutaneous Crohn's disease (CCD), particularly among female patients. The study reviewed records of 57 patients, most of whom had concurrent intestinal Crohn's disease. Biologic therapies were associated with higher rates of resolution in patients treated before their CCD diagnosis.
- ▪The study involved 57 patients treated at nine US academic centers between 2000 and 2020.
- ▪70% of patients had intestinal Crohn's disease at the time of CCD diagnosis.
- ▪Biologic or small-molecule inhibitor therapy was used in 82% of patients, with TNF-alpha inhibitors being the most common.
Medscape files mainly under health. We currently carry 231 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Medscape |
| Canonical URL | https://www.medscape.com/viewarticle/genital-lesions-most-common-presenting-sign-cutaneous-crohns-2026a1000he1?src=rss |
| Publication time | Wed, 27 May 2026 11:05:00 EDT |
| Retrieval time | 2026-05-27T15:08:01.785Z |
| Last seen | 2026-05-27T15:08:01.785Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | _O0rLfo0TVIE |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
TOPLINE:Most patients with cutaneous Crohn’s disease (CCD) in a US study were female and had concurrent intestinal Crohn’s disease and genital skin involvement, and biologic or small-molecule inhibitor therapies were associated with high rates of partial or complete resolution.METHODOLOGY:Researchers retrospectively reviewed records of 57 adult and pediatric patients (age range at diagnosis, 10-57 years; 81% female; 81% White, 9% Black, 5% Hispanic, 2% Asian) with CCD treated at nine US academic centers between 2000 and 2020.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Medscape.
Discussion
0 commentsMore from Medscape
